Aminoguanidine may be synergistic with Metformin.
Aminoguanidine is one of the new drugs in a unique class called Advanced Glycation End product inhibitors which abbreviates to AGE-inhibitor. From the information that is coming to light in clinical trials, these novel drugs may prove to be just that- age inhibitors!
Phil Micans PharmB, UK
I've been waiting to try this new anti-aging product for some time, congratulations on making it available.
D.C., New York
Product Information: Aminoguanidine (Pimagidine)
Cross-linking is medically referred to as Glycosylation and it may be responsible for many of the problems of old age, including senile cataracts, thickening of the arteries, cardiac enlargement, skin aging, some cancers and damage to the immune system. Aminoguanidine is a potent anti-glycation inhibitor, it appears to help prevent and possibility also break some protein cross-linking.
Animal experiments have shown aminoguanidine to prevent age-related heart enlargement and increase the collagen of arterial walls of aged subjects by 24-30%. Long term studies conducted in Italy, indicate that aminoguanidine reduces the "bad" form of cholesterol (LDL) in humans and improves blood platelet condition.
Recent human and animal studies also indicate that aminoguanidine improves diabetic conditions and improves the survival rates and longevity of animals. It even improves renal (kidney) condition.
Most interestingly of all, aminoguanidine may have the potential to slow the aging process by protecting the proteins that make up the human body. Proteins such as the skin proteins (collagen and elastin), eye lens protein, nerve protein and kidney proteins. All the body's proteins deteriorate with advancing age and more so in diabetes (diabetics have 2-3 times the number of cross-linked proteins when compared to non-diabetics and this has lead credence to the fact that diabetes can be viewed as a form of accelerated aging).
Aminoguanidine may be able to protect us from (or slow down the progression of) age-related cataract conditions and skin toughening and yellowing.
Aminoguanidine is an exciting new weapon in the armory of anti-aging medicine.
Doses are one tablet (150mg each) once, twice or three times a day. Aminoguanidine has a half-life of approximately 4-hours, therefore it is preferable to spread the dosage over the day with such a dose-sized tablet.
Please note that we supply a hydrochloride (HCL) based tablet. This is more expensive than a bicarbonate based version, but the HCL is more soluble, less irritating and is the type used in the clinical trials.
Aminoguanidine has not been shown to date to cause side effects any worse than nausea and headache. But as human clinical trials are still relatively limited, dosages shouldn't be exceeded unless under the supervision of a physician.
Aminoguanidine can inhibit the uptake of vitamin B6, so a B6 supplement is recommended whilst using aminoguanidine.
Aminoguanidine is an inhibitor of Advanced Glycosylation End products (AGEs). It helps prevent proteins from cross-linking and is being used in diabetes, arteriosclerosis, renal and aging disorders.
Ingredients: Contains aminoguanidine hydrochloride (150mg), microcrystalline cellulose, magnesium strerate, tricalcium phosphate and polythylene glycol per tablet.
Disclaimer: This product and its statements have not been evaluated by the FDA. This product is not intended to treat, cure or prevent any disease.
Always: Follow your physician's advice. Keep away from children, pregnant or lactating women.
Application: 1 tablet once, twice or three times per day.
Note: Store in a dark cool place. Do not use past expiry date.
© 2001 - 2008 Biogenesis Laboratories